Clinical Trial Update: Tacrolimus Treatment for Refractory PRCA [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating tacrolimus as a treatment for refractory Pure Red Cell Aplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pure Red Cell Aplasia

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Pure Red Cell Aplasia | Phase 4 | Status: UNKNOWN